N-domain of human adhesion/growth-regulatory galectin-9: Preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 6, 2010, Pages 1019-1029

  Solís, Dolores ^a,b   Maté, María Jesus ^c   Lohr, Michaela ^d   Ribeiro, João P ^c   López Merino, Lara ^a   André, Sabine ^d   Buzamet, Eliza ^a,b   Javier Cañada, F ^c   Kaltner, Herbert ^d   Lensch, Martin ^d   Ruiz, Federico M ^c   Haroske, Gunter ^e   Wollina, Uwe ^e   Kloor, Matthias ^f   Kopitz, Jürgen ^f   Sáiz, José L ^a,b   Menéndez, Margarita ^a,b   Jiménez Barbero, Jesús ^c   Romero, Antonio ^c   Gabius, Hans Joachim ^d  

^a INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d UNIVERSITY OF MUNICH   (Germany)

^e ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Ellipticity; Glycoprotein; Lectin; Promoter

Indexed keywords

ARGININE; ECALECTIN; FORSSMAN ANTIGEN; GLYCOPROTEIN; LACTOSE; LECTIN; MESSENGER RNA; PROTON; TRANSCRIPTION FACTOR; TRYPTOPHAN; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL MUTANT; CIRCULAR DICHROISM; CONTROLLED STUDY; CRYSTALLOGRAPHY; GEL FILTRATION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROGEN BOND; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIALYLATION; TANDEM REPEAT; ULTRACENTRIFUGATION;

ANIMALS; CELL ADHESION; CELL GROWTH PROCESSES; CHO CELLS; CRICETINAE; CRICETULUS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; GALECTINS; GLYCOSYLATION; HUMANS; LACTOSE; LIGANDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY;

EID: 77953741266     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.03.007     Document Type: Article

References (75)

1. Adams P.D., Grosse-Kunstleve R.W., Hung L.-W., Ioerger T.R., McCoy A.J., Moriarty N.W., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr 2002, D58:1948-1954.
2. André S., Unverzagt C., Kojima S., Frank M., Seifert J., Fink C., et al. Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. Eur J Biochem 2004, 271:118-134.
3. André S., Kojima S., Gundel G., Russwurm R., Schratt X., Unverzagt C., et al. Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties. Biochim Biophys Acta 2006, 1760:768-782.
4. André S., Pei Z., Siebert H.-C., Ramström O., Gabius H.-J. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg Med Chem 2006, 14:6314-6326.
5. INK4a-modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 2007, 274:3233-3256.
6. André S., Kozár T., Schuberth R., Unverzagt C., Kojima S., Gabius H.-J. Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties. Biochemistry 2007, 46:6984-6995.
7. André S., Maljaars C.E.P., Halkes K.M., Gabius H.-J., Kamerling J.P. Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg Med Chem Lett 2007, 17:793-798.
8. André S., Kozár T., Kojima S., Unverzagt C., Gabius H.-J. From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol Chem 2009, 390:557-565.
9. André S., Velasco-Torrijos T., Leyden R., Gouin S., Tosin M., Murphy P.V., et al. Phenylenediamine-based bivalent glycocyclophanes: synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles. Org Biomol Chem 2009, 7:4715-4725.
10. Baba M., Wada J., Eguchi J., Hashimoto I., Okada T., Yasuhara A., et al. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms. J Am Soc Nephrol 2005, 16:3222-3234.
11. Beer A., André S., Kaltner H., Lensch M., Franz S., Sarter K., et al. Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A 2008, 73A:139-147.
12. Bi S., Earl L.A., Jacobs L., Baum L.G. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J Biol Chem 2008, 283:12248-12258.
13. Brockhausen I., Schachter H. Glycosyltransferases involved in N- and O-glycan biosynthesis. Glycosciences. Status and perspectives 1997, 79-113. Chapman & Hall, Weinheim, Germany. H.-J. Gabius, S. Gabius (Eds.).
14. Čada Z., Smetana K., Lacina L., Plzáková Z., Štork J., Kaltner H., et al. Immunohistochemical fingerprinting of the network of seven adhesion/growth-regulatory lectins in human skin and detection of distinct tumour-associated alterations. Folia Biol (Praha) 2009, 55:145-152.
15. Campanero-Rhodes M.A., Menéndez M., Sáiz J.L., Sanz L., Calvete J.J., Solís D. Zinc ions induce the unfolding and self-association of boar spermadhesin PSP-1, a protein with a single CUB domain architecture, and promote its binding to heparin. Biochemistry 2006, 45:8227-8235.
16. Comelli E.M., Head S.R., Gilmartin T., Whisenant T., Haslam S.M., North S.J., et al. A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 2006, 16:117-131.
17. Cooper D.N.W. Galectinomics: finding themes in complexity. Biochim Biophys Acta 2002, 1572:209-231.
18. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr 2004, D60:2126-2132.
19. Gabius H.-J. Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal Biochem 1990, 189:91-94.
20. Gabius H.-J. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1. Biochimie 2001, 83:659-666.
21. Gabius H.-J. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit Rev Immunol 2006, 26:43-79.
22. The Sugar Code. Fundamentals of glycosciences 2009, Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
23. Gabius H.-J., Wosgien B., Hendrys M., Bardosi A. Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody. Histochemistry 1991, 95:269-277.
24. Honke K., Taniguchi N. Animal models to delineate glycan functionality. The Sugar Code. Fundamentals of glycosciences 2009, 385-401. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
25. Houzelstein D., Gonçalves I.R., Fadden A.J., Sidhu S.S., Cooper D.N.W., Drickamer K., et al. Phylogenetic analysis of the galectin family. Mol Biol Evol 2004, 21:1177-1187.
26. Ishii A., Ikeda T., Hitoshi S., Fujimoto I., Torii T., Sakuma K., et al. Developmental changes in the expression of glycogenes and the content of N-glycans in the mouse cerebral cortex. Glycobiology 2007, 17:261-276.
27. Jiménez M., Sáiz J.L., André S., Gabius H.-J., Solís D. Monomer/dimer equilibrium of the AB-type lectin from mistletoe enables combination of toxin/agglutinin activities in one protein: analysis of native and citraconylated proteins by ultracentrifugation/gel filtration and cell biological consequences of dimer destabilization. Glycobiology 2005, 15:1386-1395.
28. Jiménez-Barbero J., Dragoni E., Venturi C., Nannucci F., Ardá A., Fontanella M., et al. α-O-linked glycopeptide mimetics: synthesis, conformation analysis, and interaction with viscumin, a galactoside-binding model lectin. Chem Eur J 2009, 15:10423-10431.
29. Kageshita T., Kashio Y., Yamauchi A., Seki M., Abedin M.J., Nishi N., et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 2002, 99:809-816.
30. Kaltner H., Solís D., Kopitz J., Lensch M., Lohr M., Manning J.C., et al. Prototype chicken galectins revisited: characterization of a third protein with distinctive hydrodynamic behaviour and expression pattern in organs of adult animals. Biochem J 2008, 409:591-599.
31. Kaltner H., Solís D., André S., Lensch M., Manning J.C., Mürnseer M., et al. Unique chicken tandem-repeat-type galectin: implications of alternative splicing and a distinct expression profile compared to those of the three proto-type proteins. Biochemistry 2009, 48:4403-4416.
32. Katoh S., Ishii N., Nobumoto A., Takeshita K., Dai S.-Y., Shinonaga R., et al. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 2007, 176:27-35.
33. Kolympadi M., Fontanella M., Venturi C., André S., Gabius H.-J., Jiménez-Barbero J., et al. Synthesis and conformational analysis of (α-D-galactosyl)phenylmethane and α-,β-difluoromethane analogues: interactions with the plant lectin viscumin. Chem Eur J 2009, 15:2861-2873.
34. Kopitz J. Glycolipids. The Sugar Code. Fundamentals of glycosciences 2009, 177-198. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
35. Lahm H., Hoeflich A., André S., Sordat B., Kaltner H., Wolf E., et al. Gene expression of galectin-9/ecalectin, a potent eosinophil chemoattractant, and/or the insertional isoform in human colorectal carcinoma cell lines and detection of frame-shift mutations for protein sequence truncations in the second functional lectin domain. Int J Oncol 2000, 17:519-524.
36. Lahm H., André S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 2001, 127:375-386.
37. Ledeen R.W., Wu G. Neurobiology meets glycosciences. The Sugar Code. Fundamentals of glycosciences 2009, 495-516. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
38. Lee R.T., Lee Y.C. Neoglycoconjugates. Glycosciences. Status and perspectives 1997, 55-77. Chapman & Hall, Weinheim, Germany. H.-J. Gabius, S. Gabius (Eds.).
39. Lensch M., Lohr M., Russwurm R., Vidal M., Kaltner H., André S., et al. Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence. Int J Biochem Cell Biol 2006, 38:1741-1758.
40. Lipkowitz M.S., Leal-Pinto E., Rappoport J.Z., Najfeld V., Abramson R.G. Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J Clin Invest 2001, 107:1103-1115.
41. Lohr M., Lensch M., André S., Kaltner H., Siebert H.-C., Smetana K., et al. Murine homodimeric adhesion/growth-regulatory galectins-1, -2 and -7: comparative profiling of gene/promoter sequences by database mining, of expression by RT-PCR/immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol (Praha) 2007, 53:109-128.
42. Lohr M., Kaltner H., Lensch M., André S., Sinowatz F., Gabius H.-J. Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. Histochem Cell Biol 2008, 130:576-581.
43. López-Lucendo M.F., Solís D., Sáiz J.L., Kaltner H., Russwurm R., André S., et al. Homodimeric chicken galectin CG-1B (C14): crystal structure and detection of unique redox-dependent shape changes involving inter- and intrasubunit disulfide bridges by gel filtration, ultracentrifugation, site-directed mutagenesis, and peptide mass fingerprinting. J Mol Biol 2009, 386:366-378.
44. Lu L.-H., Nakagawa R., Kashio Y., Ito A., Shoji H., Nishi N., et al. Characterization of galectin-9-induced death of Jurkat T cells. J Biochem 2007, 141:157-172.
45. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998, 273:16976-16984.
46. Matsushita N., Nishi N., Seki M., Matsumoto R., Kuwabara I., Liu F.-T., et al. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem 2000, 275:8355-8360.
47. Miyanishi N., Nishi N., Abe H., Kashio Y., Shinonaga R., Nakakita S.-i., et al. Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family. Glycobiology 2007, 17:423-432.
48. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr 1997, D53:240-255.
49. Nagae M., Nishi N., Murata T., Usui T., Nakamura T., Wakatsuki S., et al. Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition. J Biol Chem 2006, 281:35884-35893.
50. Nagae M., Nishi N., Nakamura-Tsuruta S., Hirabayashi J., Wakatsuki S., Kato R. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J Mol Biol 2008, 375:119-135.
51. Nagae M., Nishi N., Murata T., Usui T., Nakamura T., Wakatsuki S., et al. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain. Glycobiology 2009, 19:112-117.
52. Ngamukote S., Yanagisawa M., Ariga T., Ando S., Yu R.K. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem 2007, 103:2327-2341.
53. Nishi N., Itoh A., Fujiyama A., Yoshida N., Araya S.-i., Hirashima M., et al. Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat-type galectins. FEBS Lett 2005, 579:2058-2064.
54. Nishi N., Itoh A., Shoji H., Miyanaka H., Nakamura T. Galectin-8 and galectin-9 are novel substrates for thrombin. Glycobiology 2006, 16:15C-20C.
55. Ohtsubo K., Takamatsu S., Minowa M.T., Yoshida A., Takeuchi M., Marth J.D. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 2005, 123:1307-1321.
56. Patsos G., Corfield A. O-glycosylation: structural diversity and functions. The Sugar Code. Fundamentals of glycosciences 2009, 111-137. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
57. Patsos G., André S., Roeckel N., Gromes R., Gebert J., Kopitz J., et al. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 2009, 19:726-734.
58. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612.
59. Saal I., Nagy N., Lensch M., Lohr M., Manning J.C., Decaestecker C., et al. Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol Histopathol 2005, 20:1191-1208.
60. Sato M., Nishi N., Shoji H., Seki M., Hashidate T., Hirabayashi J., et al. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 2002, 12:191-197.
61. Schwartz-Albiez R. Inflammation and glycosciences. The Sugar Code. Fundamentals of glycosciences 2009, 447-467. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
62. Seki M., Sakata K.-m., Oomizu S., Arikawa T., Sakata A., Ueno M., et al. Beneficial effect of galectin-9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 2007, 56:3968-3976.
63. Solís D., Jiménez-Barbero J., Kaltner H., Romero A., Siebert H.-C., von der Lieth C.W., et al. Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells Tissues Organs 2001, 168:5-23.
64. Solís D., Romero A., Menéndez M., Jiménez-Barbero J. Protein-carbohydrate interactions: basic concepts and methods for analysis. The Sugar Code. Fundamentals of glycosciences 2009, 233-245. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).
65. Sperandio M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 2006, 273:4377-4389.
66. Spitzenberger F., Graessler J., Schroeder H.-E. Molecular and functional characterization of galectin-9 mRNA isoforms in porcine and human cells and tissues. Biochimie 2001, 83:851-862.
67. Tanikawa R., Tanikawa T., Okada Y., Nakano K., Hirashima M., Yamauchi A., et al. Interaction of galectin-9 with lipid rafts induces osteoblast proliferation through the c-Src/ERK signaling pathway. J Bone Miner Res 2008, 23:278-286.
68. Türeci Ö., Schmitt H., Fadle N., Pfreundschuh M., Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 1997, 272:6416-6422.
69. Villalobo A., Nogales-González A., Gabius H.-J. A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol 2006, 18:1-37.
70. Wada J., Ota K., Kumar A., Wallner E.I., Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside-binding lectin. J Clin Invest 1997, 99:2452-2461.
71. Wu A.M., Singh T., Wu J.H., Lensch M., André S., Gabius H.-J. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. Glycobiology 2006, 16:524-537.
72. Wu A.M., Singh T., Liu J.-H., Krzeminski M., Russwurm R., Siebert H.-C., et al. Activity-structure correlations in divergent lectin evolution: fine specificity of chicken galectin CG-14 and computational analysis of flexible ligand docking for CG-14 and the closely related CG-16. Glycobiology 2007, 17:165-184.
73. Xu H., Storch T., Yu M., Elliott S.P., Haslam D.B. Characterization of the human Forssman synthetase gene. An evolving association between glycolipid synthesis and host-microbial interactions. J Biol Chem 1999, 274:29390-29398.
74. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005, 6:1245-1252.
75. Zuber C., Roth J. N-glycosylation. The Sugar Code. Fundamentals of glycosciences 2009, 87-110. Wiley-VCH, Weinheim, Germany. H.-J. Gabius (Ed.).